Linked Life Data

19701153

Source:http://linkedlifedata.com/resource/pubmed/id/19701153

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2009-8-24
pubmed:abstractText
Approximately one third of non-small cell lung cancer (NSCLC) patients will present with locally advanced, stage III disease. With the use of pretreatment positron emission testing and mediastinal lymph node sampling, classifying stage III NSCLC has become more involved and treatment strategies have shifted from single modality thoracic radiation to combined chemoradiotherapy. This article reviews evidence-based strategies in the treatment of locally advanced NSCLC and presents new efforts for improving the poor prognosis of this disease by incorporating novel chemotherapy and biologic based regimens.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1543-0790
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
455-64, 479-80
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Treatment of locally advanced non-small cell lung cancer.
pubmed:affiliation
Section of Medical Oncology, Rush University Medical Center, Chicago, IL 60612, USA. mary_fidler@rush.edu
pubmed:publicationType
Journal Article, Review